Development & Manufacturing / Newly Independent CDMO Skyepharma Looks to Expansion
Fresh from a management buyout and the establishment of Skyepharma as an independent company, Managing Director…
Top Stories
Switzerland / Upcoming Cost Containment Packages: Industry Key Concerns
While once considered the land of milk and honey within Europe in terms of market access and reimbursement for innovative pharmaceuticals, Switzerland is increasingly tightening its belt on this front…
Southeast Asia / Kalbe Underwhelms in Indonesia; Novavax Looks to Filipino Vaccine Manufacturing; Thai Cannabis Market Boom
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma,…
Hong Kong / HKEX’s Aim to Become World’s #1 Biotech Listing Hub & Challenges for New CEO
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs…
Singapore / A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy,…
Mexico / Health & Patent Rights During the COVID-19 Pandemic
There is no doubt that COVID-19 has impacted almost every aspect of our lives. Due to the ongoing health crisis,…
Aducanumab Approval / Opening the Floodgates for a New Era of Alzheimer’s Treatment?
With the US FDA’s controversial recent decision to approve Biogen and Eisai’s aducanumab – the first approval…
In Conversation
Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland
Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide, forming collaborations between entrepreneurs and the Johnson & Johnson Family of Companies’ global healthcare businesses. Michael Hübner, Early Innovation Partnering Lead and member of the Swiss Johnson & Johnson Leadership Team discusses how they support breakthrough early innovation through collaboration and strategic partnerships; JLABS, a global network of…
Latest Reports
Focus on Europe
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
Spanish Pharma News: Market Growth; Esteve’s US Expansion;…
The latest from Spanish pharma, including the acquisition of PTS by a private…
MSD Switzerland AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich…
Read more: Europe >>
Focus on MEA
5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…
Turkey: Koçak Farma & The Push for Homegrown COVID-19…
As the international community continues its quest to vaccinate the global…
Georg Schroeckenfuchs of Novartis: ‘Shooting for the…
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the…
Read more: MEA >>
Focus on Switzerland
Switzerland’s Quest for Alternatives to Animal Testing of…
Animal testing for medicinal purposes is back under the spotlight in Switzerland…
Switzerland’s Upcoming Cost Containment Packages:…
While once considered the land of milk and honey within Europe in terms of…
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
MSD Switzerland AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich…
Read more: Switzerland >>
Focus on China
China Pharma News: BioNTech-Fosun JV; Patent Law Revamp;…
The latest news from Chinese pharma, including an overhaul of the country’s…
APAC: Generic Penetration by Country
Generics penetration in the Asia-Pacific region by country for 2018. A full 90.3…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
China: EpimAb Looks to 2022 IPO & Global Leadership in…
Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb…
Read more: China >>
Focus on Vaccines
Germany Pharma News: Merck KGaA Expecting More COVID-Related…
The latest news from German pharma, including a new US leadership team and more…
Industry Warns of Vaccine Manufacturing Bottlenecks;…
Big Pharma’s representatives are warning of upcoming bottlenecks in the…
Southeast Asia: Kalbe Underwhelms in Indonesia; Novavax…
The latest from the pharma industry in Southeast Asia, including underwhelming…
IP PACT: A Journey, Not a Destination
The issue of COVID-19 vaccine access in developing nations has thrust…
Read more: Vaccines >>
Focus on USA
Aducanumab Approval: Opening the Floodgates for a New Era of…
With the US FDA’s controversial recent decision to approve Biogen and…
USA: Importance of the Patient Voice in Drug Development:…
Writing in the May edition of DIA’s Global Forum magazine, Erica Lyons, Sarrit…
Mexico-US Vaccine Tourism: Closed Borders, Fear of Fakes…
While Mexico struggles with its COVID-19 vaccination campaign, residents of the…
Moderna: Bullish Bancel “Not Losing Sleep” over COVID-19…
The day the Biden administration announced its support for the waiver of IP…
Read more: USA >>
Focus on Singapore
Singapore: Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
Singapore: A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth…
APAC: Diagnostics in the Post-COVID Era
COVID-19 has pushed diagnostics to the forefront of healthcare conversations…